EBioMedicine

Elsevier

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

EBioMedicine is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 6,810 USD. Declared review time at DOAJ: 27 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2352-3964
Country
Netherlands
Languages
english
Access
Open access
Declared publication charge
6,810 USD
Articles in DOAJ
5466
Declared review time
27 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2015-08-13
  • MEDLINE · 2015-01-01
  • PUBMED · 2014-11-01
Indexing
DOAJ · MEDLINE · PUBMED
APC
6,810 USD
Declared review time (DOAJ)
27 weeks
Actual review time (measured)
188 days received→accepted — computed from PubMed (n=96)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

5466

Most recent article

last month

Average review time (journal-declared via DOAJ)

27weeks

Works in OpenAlex

6310

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

180

i10-index

3940

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2015-08-13
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
94%
ORCID iDs in current deposits
89%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
eBioMedicine
Source type
journal
NLM unique ID (PubMed)
101647039
Classification3

Subjects (DOAJ)

Medicine: Medicine (General)

LCC codes

RR5-920

Subject areas

  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • Gut microbiota and health
  • Gut microbiota and health
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • HIV Research and Treatment
Show all subjects (50)
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Genetic Associations and Epidemiology
  • Genetic Associations and Epidemiology
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • vaccines and immunoinformatics approaches
  • vaccines and immunoinformatics approaches
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Immune responses and vaccinations
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Immune responses and vaccinations
  • Long-Term Effects of COVID-19
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Long-Term Effects of COVID-19
  • Mosquito-borne diseases and control
  • Mosquito-borne diseases and control
  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Immune cells in cancer
  • Alzheimer's disease research and treatments
  • Immune cells in cancer
  • Alzheimer's disease research and treatments
  • T-cell and B-cell Immunology
  • T-cell and B-cell Immunology
  • Liver Disease Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Metabolomics and Mass Spectrometry Studies
  • Metabolomics and Mass Spectrometry Studies
  • Respiratory viral infections research
  • Respiratory viral infections research

Keywords (DOAJ)

  • basic science
  • clinical science
  • translational
  • genetics
  • drug targeting
  • biomedicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: